These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33124555)

  • 1. Myositis-specific autoantibodies and their associated phenotypes in juvenile dermatomyositis: data from a German cohort.
    Horn S; Minden K; Speth F; Schwarz T; Dressler F; Grösch N; Haas JP; Hinze C; Horneff G; Hospach A; Kallinich T; Klotsche J; Köstner K; Meisel C; Niewerth M; Oommen PT; Schütz C; Weller-Heinemann F; Unterwalder N; Sengler C
    Clin Exp Rheumatol; 2022 Feb; 40(2):433-442. PubMed ID: 33124555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies.
    Perron MM; Vasquez-Canizares N; Tarshish G; Wahezi DM
    Pediatr Rheumatol Online J; 2021 Jun; 19(1):92. PubMed ID: 34118936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary function and autoantibodies in a long-term follow-up of juvenile dermatomyositis patients.
    Mathiesen PR; Buchvald F; Nielsen KG; Herlin T; Friis T; Nielsen S
    Rheumatology (Oxford); 2014 Apr; 53(4):644-9. PubMed ID: 24310298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
    Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent research on myositis-specific autoantibodies in juvenile dermatomyositis.
    He L
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):1064-1068. PubMed ID: 34719424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile dermatomyositis associated with autoantibodies to small ubiquitin-like modifier activating enzyme: a report of 4 cases from North India and a review of literature.
    Vignesh P; Barman P; Basu S; Mondal S; Ishran B; Kumrah R; Dod A; Garg R; Rawat A; Singh S
    Immunol Res; 2023 Feb; 71(1):112-120. PubMed ID: 36278969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The analysis of clinical phenotypes and autoantibodies in juvenile dermatomyositis].
    Li DM; Wang L; Liu MY; Xu L; Tang XM
    Zhonghua Er Ke Za Zhi; 2020 Dec; 58(12):966-972. PubMed ID: 33256317
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis.
    Soponkanaporn S; Deakin CT; Schutz PW; Marshall LR; Yasin SA; Johnson CM; Sag E; Tansley SL; McHugh NJ; Wedderburn LR; Jacques TS
    Neuropathol Appl Neurobiol; 2019 Jun; 45(4):410-420. PubMed ID: 29770465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report.
    Kishi T; Tani Y; Okiyama N; Mizuochi K; Ichimura Y; Harigai M; Nagata S; Miyamae T
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):34. PubMed ID: 33740993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study.
    Tansley SL; Betteridge ZE; Gunawardena H; Jacques TS; Owens CM; Pilkington C; Arnold K; Yasin S; Moraitis E; Wedderburn LR; McHugh NJ;
    Arthritis Res Ther; 2014 Jul; 16(4):R138. PubMed ID: 24989778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
    Kim H; Gunter-Rahman F; McGrath JA; Lee E; de Jesus AA; Targoff IN; Huang Y; O'Hanlon TP; Tsai WL; Gadina M; Miller FW; Goldbach-Mansky R; Rider LG
    Arthritis Res Ther; 2020 Apr; 22(1):69. PubMed ID: 32252809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features, muscle biopsy scores, myositis specific antibody profiles and outcome in juvenile dermatomyositis.
    Sag E; Demir S; Bilginer Y; Talim B; Haliloglu G; Topaloglu H; Ozen S
    Semin Arthritis Rheum; 2021 Feb; 51(1):95-100. PubMed ID: 33360233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-depth proteomic analysis of juvenile dermatomyositis serum reveals protein expression associated with muscle-specific autoantibodies.
    Sato H; Inoue Y; Kawashima Y; Konno R; Ohara O; Kuwana M; Kobayashi N; Takezaki S; Akioka S
    Rheumatology (Oxford); 2023 Oct; 62(10):3501-3506. PubMed ID: 37052527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology.
    Gómez GN; Pérez N; Braillard Poccard A; Gómez RA; Costi AC; García MA; Viola M; Benitez A; Aciar MM; Crespo Espíndola M; Yucra D; Cosatti MA; Pisoni C; Capelusnik D; Lojo MN; Barrios BI; Rivero M; Kisluk B; Granel A
    Clin Rheumatol; 2021 Nov; 40(11):4473-4483. PubMed ID: 34159491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis.
    Mamyrova G; Kishi T; Targoff IN; Ehrlich A; Curiel RV; Rider LG;
    Rheumatology (Oxford); 2018 Nov; 57(11):1956-1963. PubMed ID: 30016492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report.
    Nainia K; Aouzal MA; Ouafik I; Charhbili M; Bouchhab A; Daoudi A; Tizki S; Chakiri R
    Pediatr Rheumatol Online J; 2024 May; 22(1):57. PubMed ID: 38773611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America.
    Mamyrova G; Kishi T; Shi M; Targoff IN; Huber AM; Curiel RV; Miller FW; Rider LG;
    Rheumatology (Oxford); 2021 Apr; 60(4):1839-1849. PubMed ID: 33140079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The arthritis of inflammatory childhood myositis syndromes.
    Tse S; Lubelsky S; Gordon M; Al Mayouf SM; Babyn PS; Laxer RM; Silverman ED; Schneider R; Feldman BM
    J Rheumatol; 2001 Jan; 28(1):192-7. PubMed ID: 11196524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry.
    Carriquí-Arenas S; Mosquera JM; Quesada-Masachs E; López M; Clemente D; Boteanu A; Udaondo C; de Inocencio J; Nieto JC; Riancho L; Núñez E; Sánchez-Manubens J; Lirola MJ; Roldán R; Camacho M; Martínez M; Medrano M; Alcañiz P; Antón J; Iglesias E
    Pediatr Rheumatol Online J; 2024 Jul; 22(1):66. PubMed ID: 39039532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.